arrow
J

Jeong-Seon Ryu

Inha University
H指数:27
被引数:2,521

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-World Outcomes of Brigatinib Compared to Alectinib as a Second-Line Therapy After Crizotinib in Advanced Anaplastic Lymphoma Kinase Positive Non-Small Cell Lung Cancer Patients

与阿来替尼相比,brigatinib作为克唑替尼后二线疗法在晚期间变性淋巴瘤激酶阳性非小细胞肺癌患者中的真实世界疗效。

2025-10-010
OAAI
Real-world first-line afatinib for advanced EGFR mutation-positive non-small cell lung cancer in Korea: updated survival data

真实世界一线阿法替尼治疗晚期EGFR突变阳性非小细胞肺癌: 更新的生存数据

2023-11-010
OAAI
Real-world analysis of first-line afatinib in patients with EGFR-mutant non-small cell lung cancer and brain metastasis: survival and prognostic factors

EGFR突变非小细胞肺癌脑转移患者一线阿法替尼的真实世界分析: 生存和预后因素

2023-06-012
OAAI
Real-world experience of afatinib as first-line therapy for advanced EGFR mutation-positive non-small cell lung cancer in Korea

韩国阿法替尼一线治疗晚期EGFR突变阳性非小细胞肺癌的真实经验

2021-12-0111
OAAI
Low-level expression of necroptosis factors indicates a poor prognosis of the squamous cell carcinoma subtype of non-small-cell lung cancer

坏死因子的低水平表达表明非小细胞肺癌的鳞状细胞癌亚型预后不良

2021-03-0122
OAAI